Form 4: Palisade Bio CFO Reports Stock Transaction
Insider Transaction (Form 4)
John David Finley, CEO, CFO and a Director of Palisade Bio, Inc., reported multiple transactions in common stock on August 19, 2026.
Summary
- Bona fide gift: disposed of 88,400 Common Stock on August 19, 2026; holds 129,288 after (Direct).
- Bona fide gift: acquired 88,400 Common Stock on August 19, 2026; holds 88,451 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John David Finley — Director, Officer (CEO, CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Bona fide gift | Common Stock | 88,400 | — | — | 129,288 |
| 2026-08-19 | Bona fide gift | Common Stock | 88,400 | — | — | 88,451 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Bona fide gift (88,400 shares) |
| 2026-08-19 | Bona fide gift (88,400 shares) |
Keywords
insider transaction, Form 4, PALI, PALISADE BIO, INC., neutral, John David Finley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.